This content is in French.
ALS: strengthening to withstand
16 juin 2025

#ALS #Neurodegeneration
#RespiratoryRehabilitation #RMT
Amyotrophic lateral sclerosis (ALS) is a severe, progressive, and incurable neurodegenerative disease, characterized by the degeneration of cortical, bulbar, and spinal motor neurons. It leads to generalized muscle weakness, loss of autonomy, and eventually terminal respiratory failure, which is the main cause of death. The average life expectancy is 3 to 5 years after symptom onset.
The weakness of respiratory muscles, particularly the diaphragm, gradually impairs ventilation, reduces coughing ability, and promotes the accumulation of bronchial secretions, with recurrent respiratory infections. However, the available treatments only partially address these mechanisms. Respiratory rehabilitation, especially respiratory muscle training (RMT), could improve quality of life, functional capacity, or even patient survival. Nevertheless, available data remain fragmented.
Amyotrophic lateral sclerosis (ALS) is a severe, progressive, and incurable neurodegenerative disease, characterized by the degeneration of cortical, bulbar, and spinal motor neurons. It leads to generalized muscle weakness, loss of autonomy, and eventually terminal respiratory failure, which is the main cause of death. The average life expectancy is 3 to 5 years after symptom onset.
The weakness of respiratory muscles, particularly the diaphragm, gradually impairs ventilation, reduces coughing ability, and promotes the accumulation of bronchial secretions, with recurrent respiratory infections. However, the available treatments only partially address these mechanisms. Respiratory rehabilitation, especially respiratory muscle training (RMT), could improve quality of life, functional capacity, or even patient survival. Nevertheless, available data remain fragmented.
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Benzo-Iglesias, et al. (2025). Efficacy of respiratory muscle training in improving pulmonary function and survival in patients with amyotrophic lateral sclerosis […]. Therapeutic advances in respiratory disease, 19, 17534666251346095
View the source


